Category: <span>Stem Cell Therapy</span>

During stem cell therapy, cells are grown and manipulated in a controlled culture to produce specific cells. This is done to help promote a tissue repair response in injured tissue. In some cases, patients notice improvements within a few weeks. In other cases, it can take a few months for changes to be seen. The goal of stem cell therapy is to restore damaged tissue and extend life. However, there are risks to this form of treatment. Learn the facts here now ZignaGenix 

The most common risks are bacterial infections and viral infections. While both types of infections are usually mild, they can be dangerous for people with normal immune systems. They can be transmitted to the recipient during transplant procedures. They can also be reactivated once the recipient’s immune system is restored. Similarly, fungus infections can be common. People may also experience mild infections, such as fever or chills, after the transplant procedure. Depending on the severity, patients may need to take antiviral drugs and white blood cell transfusions.

Another common risk is immune rejection. This is often treated by cutting back on immunosuppressant drugs. In other cases, the patient may require a platelet transfusion. People with low platelet counts may experience bleeding gums and easy bruising. This is caused by the body’s lack of ability to produce platelets.

The third most common risk is human pathogen transmission. The patient may get a life-threatening infection if he or she is infected with a pathogen during a transplant procedure. The patient may be at risk if the transplant team does not advise special precautions. This type of risk is usually associated with allogeneic transplants.

The fourth most common risk is adventitious agents. These include viruses, fungus, and bacteria. These infections can be treated with antiviral drugs, but patients may also need to take antibiotics and antifungal drugs. This type of risk is associated with graft failure, as well. This occurs when the patient’s body does not accept the new stem cells.

Another common risk is the potential for tumour formation. This can occur with both embryonic and adult stem cells. The risk of tumour formation is usually seen as a key obstacle to the safe use of stem-cell based medicinal products. However, other factors may also contribute to tumour formation.

Researchers have also discovered that some of the cells that are produced by embryonic stem cells can transform into cancer cells. They have also studied how these cells can be programmed to specialize into tissue-specific cells. These studies have led to the idea that these cells may one day be used to treat brain diseases. These types of cells are called pluripotent cells. These cells are capable of transforming into almost any cell type.

In the future, scientists may be able to use stem cells to treat diseases such as Parkinson’s disease, which results from damage to brain cells. In order to help doctors develop these treatments, scientists have isolated and manipulated stem cells from adult tissue. These types of cells have also been used to treat osteogenesis imperfecta, coronary artery disease, and chronic spinal cord injury.

Business NAP
ZignaGenix
888 Prospect St La
Jolla, CA 92037
(619) 457-6100